Scientific Articles on Psychedelics: Difference between revisions
TheTraveler (talk | contribs) |
TheTraveler (talk | contribs) |
||
| Line 202: | Line 202: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:cluster headache lsd psilocybin.pdf|Cluster headache lsd psilocybin]] | ||
| | | | ||
|0px | |0px | ||
| Line 208: | Line 208: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:effects of psilocybin on humans.pdf|Effects of psilocybin on humans]] | ||
| | | | ||
|0px | |0px | ||
| Line 214: | Line 214: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:effects of psilocybin on perception of time.pdf|Effects of psilocybin on perception of time]] | ||
| | | | ||
|0px | |0px | ||
| Line 220: | Line 220: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psilocybin and mystical experiences.pdf|Psilocybin and mystical experiences]] | ||
| | | | ||
|0px | |0px | ||
| Line 226: | Line 226: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Psilocybin and OCD.pdf|Psilocybin and OCD]] | ||
| | | | ||
|0px | |0px | ||
| Line 232: | Line 232: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psilocybin investigator brochure.pdf|Psilocybin investigator brochure]] | ||
| | | | ||
|0px | |0px | ||
| Line 238: | Line 238: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psilocybin, attention and working memory.pdf|Psilocybin, attention and working memory]] | ||
| | | | ||
|0px | |0px | ||
| Line 244: | Line 244: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psychedelic mushrooms in buddhist tradition.pdf|Psychedelic mushrooms in buddhist tradition]] | ||
| | | | ||
}} | }} | ||
==Salvia Divinorum== | ==Salvia Divinorum== | ||
Revision as of 21:37, 16 February 2009
 |
Note: | This page is a work in progress -- its content throughout is not yet complete. |
Ayahuasca
|
Ayahuasca and SSRI Interactions | Callaway, J.T., C.S. Grob. (October-December 1998). Journal of Psychoactive Drugs. pp. 367-369. |
|
|
Ayahuasca Adolescents ritual use | Doering-Silveira et al. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2). pp. 141-144. |
|
|
ayahuasca first time psychological after effects | Hoffman et al. (Spring 2001). Multidisciplinary Association for Psychedelic Studies. pp. 25-30. |
|
|
Ayahuasca and human destiny | McKenna, Dennis J. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2) pp. 231-234. |
|
|
Another Ayahuasca EEG study | Riba et al. (2002). British Journal of Clinical Pharmacology. Vol. 53. Blackwell Science Ltd. pp. 617-628. |
|
|
Ayahuasca in adolescence psychiatric evaluation |
|
|
ayahuasca in cross cultural perspective |
|
|
Ayahuasca neuroimaging |
|
|
Bringing Ayahuasca to clinical laboratory |
|
|
Effects of ayahuasca on panic and anxiety.pdf |
|
|
Globalization of ayahuasca |
|
|
Human pharmacology of ayahuasca |
|
|
Pharmacokinetics of hoasca in healthy humans |
|
|
Risk assessment of ritual ayahuasca use |
|
|
Thesis - Ayahuascapharmacology part1 |
|
|
Thesis - ayahuascapharmacology part2 |
|
|
Various alkaloid profiles in aya decoction |
DMT
|
|
DMT and BCarbolines in human plasma after dose |
|
|
DMT endogenous anxiolytic role |
|
|
DMT in psychiatric patients |
|
|
DMT psychopharmacology |
|
|
Excretion of DMT in Psychiatric Patients |
Ibogaine
|
|
Fatalities after ibogaine use |
|
|
Ibogaine and cocaine abuse |
|
|
Ibogaine and facilitation of memory retrieval |
|
|
Ibogaine mechanisms of anti addiction |
|
|
Ibogaine safety and efficacy |
LSD
|
|
Long term effects of LSD |
|
|
Therapy with LSD |
Peyote
|
|
A Study on mescaline in human subjects |
|
|
Peyote long term psychological cognitive effects |
|
|
Prehistoric peyote use |
Psilocybin
|
|
Cluster headache lsd psilocybin |
|
|
Effects of psilocybin on humans |
|
|
Effects of psilocybin on perception of time |
|
|
Psilocybin and mystical experiences |
|
|
Psilocybin and OCD |
|
|
Psilocybin investigator brochure |
|
|
Psilocybin, attention and working memory |
|
|
Psychedelic mushrooms in buddhist tradition |
Salvia Divinorum
|
|
Media:placehere |
|
|
Media:placehere |
[{UP}PDF/Science/salvia divinorum pattern of use.pdf|Salvia divinorum pattern of use.pdf] [{UP}PDF/Science/Salv_A_PNAS.pdf|Salv_A_PNAS.pdf]
Other
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
[{UP}PDF/Science/bufo alvarius - a potent hallucinogen.pdf|Bufo alvarius - a potent hallucinogen.pdf] [{UP}PDF/Science/entheogens and education potential.pdf|Entheogens and education potential.pdf] [{UP}PDF/Science/hallucinogens and redemption.pdf|Hallucinogens and redemption.pdf] [{UP}PDF/Science/HPPD - flashbacks.pdf|HPPD - flashbacks.pdf] [{UP}PDF/Science/JPharmBioAn-41-3-872.pdf|JPharmBioAn-41-3-872.pdf] [{UP}PDF/Science/Mining_Recepterome_Review_JBC.pdf|Mining_Recepterome_Review_JBC.pdf]
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
[{UP}PDF/Science/natural hallucinogens growing in USA.pdf|Natural hallucinogens growing in USA.pdf] [{UP}PDF/Science/Nichols - Hallucinogens.pdf|Nichols - Hallucinogens.pdf] [{UP}PDF/Science/pharmañopo - Yopo pharmacology.pdf|Pharmañopo - Yopo pharmacology.pdf] [{UP}PDF/Science/pharmepena - epena pharmacology.pdf|Pharmepena - epena pharmacology.pdf] [{UP}PDF/Science/Proposed Mechanism for Dreams and Sleep.pdf|Proposed Mechanism for Dreams and Sleep.pdf] [{UP}PDF/Science/psychedelic adverse effects.pdf|Psychedelic adverse effects.pdf]
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
|
|
Media:placehere |
[{UP}PDF/Science/Psychointegrators multidisciplinary approach.pdf|Psychointegrators multidisciplinary approach.pdf] [{UP}PDF/Science/Psychopharmacology of hallucinogens.pdf|Psychopharmacology of hallucinogens.pdf] [{UP}PDF/Science/psychosis and hallucinogens consciousness model.pdf|Psychosis and hallucinogens consciousness model.pdf] [{UP}PDF/Science/reducing drug problems with set and setting.pdf|Reducing drug problems with set and setting.pdf] [{UP}PDF/Science/serotonin and hallucinogens.pdf|Serotonin and hallucinogens.pdf] [{UP}PDF/Science/study of Values of psychedelic users.pdf|Study of Values of psychedelic users.pdf]
